uce
ProgressImage ProgressImage
Oxygenta Pharmaceutical Ltd
Pharmaceuticals - Indian - Bulk Drugs
BSE Code 524636 border-img ISIN Demat INE102E01018 border-img Book Value -7.46 border-img NSE Symbol N.A border-img Div & Yield % 0 border-img Market Cap ( Cr.) 127.4 border-img P/E 0 border-img EPS 0 border-img Face Value 10
Quarters
ParticularsDec 2023
()
Sep 2023
()
Jun 2023
()
Gross Sales9.1513.086.86
Other Operating Income0.000.000.00
Other Income 0.030.000.00
Total Income9.1813.086.86
Total Expenditure 11.6715.0810.63
PBIDT-2.49-2.00-3.76
Interest 0.360.340.29
PBDT-2.86-2.35-4.06
Depreciation0.690.830.50
Tax0.000.000.00
Fringe Benefit Tax0.000.000.00
Deferred Tax0.23-0.020.00
Reported Profit After Tax-3.78-3.16-4.56
Extra-ordinary Items -0.05-0.03-0.13
Adjusted Profit After Extra-ordinary item-3.73-3.13-4.43
    
EPS (Unit Curr.)-0.99-0.87-1.65
EPS (Adj) (Unit Curr.)-0.99-0.87-1.65
Calculated EPS (Unit Curr.)-1.13-0.94-1.36
Calculated EPS (Adj) (Unit Curr.)-1.13-0.94-1.36
Calculated EPS (Ann.) (Unit Curr.)-4.51-3.77-5.45
Calculated EPS (Adj) (Ann.) (Unit Curr.)-4.51-3.77-5.45
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity33.4833.4833.48
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)-27.21-15.29-54.81
PBDTM(%)-31.26-17.97-59.18
PATM(%)-41.31-24.16-66.47
x
x
×
Let's Chat
close
refresh